- Tempus | AI-Powered Precision Medicine Genomic Testing
Tempus has built the world’s largest library of clinical molecular data and an operating system to make that data accessible and useful, starting with cancer
- Tempus | Accounts
Trouble logging in?
- Tempus AI - Wikipedia
Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM " [6][7]
- Tempus AI (TEM) Stock Price, News Analysis - MarketBeat
Should You Buy or Sell Tempus AI Stock? Get The Latest TEM Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat
- Tempus AI: An Attractive Entry Point At Current Prices
Tempus AI's integrated genomic and clinical data flywheel creates a defensible moat Read why I'm rating TEM stock a Strong Buy
- Tempus AI, Inc. (TEM) Company Profile Facts - Yahoo Finance
See the company profile for Tempus AI, Inc (TEM) including business summary, industry sector information, number of employees, business summary, corporate governance, key executives and their
- Tempus Hub
Tempus Hub provides a secure platform for managing your Tempus-related activities and information
- Tempus AI Stock Gains Following the ALERT Trial Result Announcement
Tempus AI says ALERT trial met endpoint; ECN alerts beat usual care and interventions TEM saw alerts drive 40% more valve procedures and 27% more heart team evaluations within 90 days TEM trial
|